Studies have shown that patients with inflammatory bowel disease (IBD) are less likely than patients without IBD to receive needed preventive health maintenance. Effective preventive measures are critical in reducing morbidity, hospitalization, and surgery as well as improving disease-free remission and quality of life in patients with IBD. It is key for clinicians working in both primary care and gastroenterology settings to understand the preventive health maintenance needs of their patients with IBD. Clinicians should tailor their approach based on patient age as preventive health guidelines and vaccination guidelines are age specific. As 25% of patients with IBD are diagnosed before age 20, it is critical that providers be aware of screening recommendations specific to the pediatric patient population.
After completion of this Adaptive Learning OnDemand activity developed by Dr. Anita Afzali, learners will be able to manage and maintain patient vaccinations, perform appropriate and regular screenings for cancer and depression/anxiety, and effectively provide age-specific preventive care for patients with IBD by using current guidelines and a team-based approach.
Supported by an educational grant from Pfizer Inc.
Community gastroenterologists, physician associates (PAs), nurse practitioners (NPs), pharmacists, primary care physicians, and pediatricians
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Afzali reports the following financial relationships:
Consultant: Abbvie Inc.; Arena Pharmaceuticals, Inc.; Bristol Myers Squibb; DiaSorin Molecular LLC; Eli Lilly and Company; Gilead Sciences, Inc.; Janssen Pharmaceuticals; Pfizer Inc.; Takeda Pharmaceutical Company; and TLL Pharmaceuticals
Grants: AbbVie Inc.; Bristol Myers Squibb; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Pfizer Inc.; and Takeda Pharmaceutical Company.
Other financial or material support: Co-Founder, Board Member of IBD Horizons.
Co-Founder, Board Member; Scrubs & Heels, LLC.
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.